Cardiovascular symptoms and risks of subclinical dysthyroidism;Manifestations et risques cardiovasculaires des dysthyroïdies infracliniques

Revue de Medecine Interne

Volumn 25, Issue 3, 2004, Pages 207-216

  Arrivie, J ^a,b   Sbragia, P ^a,b   Denizot, A ^a,b   Paganelli, F ^a,b   Oliver, C ^a,b  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Atrial fibrillation; Cardiovascular risks; Coronary atherosclerosis; Subclinical hyperthyroidism; Subclinical hypothyroidism

Indexed keywords

LEVOTHYROXINE; LIPID; THYROID HORMONE; THYROTROPIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; DYSTHYROIDISM; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID METABOLISM; MEDICAL DECISION MAKING; MYOCARDIAL DISEASE; PATIENT; PHYSICIAN; PREVALENCE; REVIEW; RISK ASSESSMENT; SYMPTOM; THYROID DISEASE;

EID: 1442326303     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00172-3     Document Type: Short Survey

References (73)

1. Surks M.I., Ocampo E. Subclinical thyroid disease. Am. J. M. 100:1996;217-223.
2. Klein M., Pascal V., Aubert V., Weryha G., Danchin N., Leclère J. Cœur et thyroïde. Ann. Endocrinol. 56:1995;473-486.
3. Gomberg-Maitland M., Frishman W.H. Thyroid hormone and cardiovascular disease. Am. Heart J. 135:1998;187-196.
4. Samuels M.H. Subclinical thyroid disease in the elderly. Thyroid. 8:1998;803-813.
5. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. M. 344:2001;501-509.
6. Toft A.D. Subclinical hyperthyroidism. N. Engl. J. M. 345:2001;512-516.
7. Nicoloff J.T., Spencer C.A. The use and misuse of the sensitive Thyrotropin assay. J. Clin. Endocrinol. Metab. 71:1990;553-558.
8. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Braverman L.E. Serum TSH, T4, and thyroid antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (Nhanes III). J. Clin. Endocrinol. Metab. 87:2002;489-499.
9. Goichot B., Sapin R., Schlienger J.L. Les dyshormonémies des affections non thyroïdiennes: données phsiopathologiques nouvelles. Rev Med Interne. 19:1998;640-648.
10. Parle J.V., Franklyn J.A., Cross K.W., Jones S.C., Sheppard M.C. Prevalence and follow-up of abnormal TSH concentrations in the elderly in the United Kingdom. Clin. Endocrinol. 34:1991;77-83.
11. Spencer C.A., Lo Presti J.S., Patel A., Guttler R.B., Eigen A., Shen D., et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J. Clin. Endocrinol. Metab. 70:1990;453-460.
12. Eggertsen R., Petersen K., Lundberg P.A., Nystrom E., Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. Br. Med. J. 297:1988;1586-1592.
13. Sawin C.T., Geller A., Kaplan M.M., Bacharach P., Wilson P.W.F., Hershman J.M. Low serum thyrotropin (thyroid stimulating hormone) in older patients without hyperthyroïdism. Arch. Intern. M. 151:1991;165-168.
14. Konno N., Yuri K., Taguchi H., Miura K., Taguchi S., Hagiwara K., et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid auto-antibody and urinary iodide déterminations. Clin. Endocrinol. 38:1993;273-281.
15. Sawin C.T., Geller A., Wolf P.A., Belanger A.J., Baker E., Bacharach P., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. M. 331:1994;1249-1252.
16. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. M. 160:2000;526-534.
17. Wiersenga W.M. Subclinical hypothyroidism and hyperthyroidism. I prevalence and clinical relevance. Neth. J. M. 46:1995;197-204.
18. Charkes N.D. The many causes of subclinical hyperthyroidism. Thyroid. 6:1996;391-396.
19. Leese G.P., Jung R.T., Guthrie C., Waugh N., Browning M.C.K. Morbidity in patients on L-thyroxine a comparison of those with a normal TSH to those with a suppressed TSH. Clin. Endocrinol. 37:1992;500-503.
20. Auer J., Scheibner P., Mische T., Langsteger W., Eber O., Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J. 142:2001;838-842.
21. Petersen K., Begtsson C., Lapidus L., Lindstedt G., Nystrom E. Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch. Intern. M. 150:1990;2077-2081.
22. Peters A., Ehlers M., Blank B., Exler D., Falk C., Kohlman T., et al. Excess triiodothyronine as a risk factor for coronary events. Arch. Int. M. 160:2000;1993-1999.
23. Biondi B., Fazio S., Carella C., Amato G., Cittadini A., Lupoli G., et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab. 77:1993;334-338.
24. Fazio S., Biondi B., Carella C., Sabatini D., Cittadini A., Panza N., et al. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effects of β-blockade. J. Clin. Endocrinol. Metab. 80:1995;2222-2226.
25. Biondi B., Fazio S., Cuocolo A., Sabatini D., Nicolai E., Lombardi G., et al. Impaired cardiac eserve and exercice capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab. 81:1996;4224-4228.
26. Jennings P.E., O'Malley B.P., Griffin K.E., Northover B., Rosenthal P.D. Relevance of increased serum thyroxine concentrations associated with normal serum triiodotyronine values in hypothyroid patient's receiving thyroxine: A case for "tissue thyrotoxicosis" Br. Med. J. 289:1984;1645-1647.
27. Chïng G.W., Franklin J.A., Stallard T.J., Daykin J., Sheppard M.C., Gammage M.C. Cardiac hypertrophy as a results of long-term thyroxine therapy and thyrotoxicosis. Heart. 75:1996;363-368.
28. Shapiro L.E., Sievert R., Ong L., Ocampo E.L., Chance R.A., Lee M., et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J. Clin. Endocrinol. Metab. 82:1997;2592-2595.
29. Petretta M., Bonaduce M., Spinelli L., Vicario M.L.E., Nuzzo V., Marciano F., et al. Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroïdism. Eur. J. Endocrinol. 145:2001;691-696.
30. Tenerz A., Forberg R., Jansson R. Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J. Intern M. 228:1990;229-233.
31. Parle J.V., Maisonneuve P., Sheppard M.C., Boyle P., Franklyn J.A. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-years cohort study. Lancet. 358:2001;861-865.
32. Kahaly G.J., Nieswandt J., Mohr-Kahaly S. Cardiac risks of hyperthyroidism in the elderly. Thyroid. 8:1998;1165-1169.
33. Singer P.A., Cooper D.S., Levy E.G. Treatment guidelines for patients with hyperthyroidie and hypothyroidism. JAMA. 273:1995;808-812.
34. Vanderpump M.P., Ahlquist J.A., Franklyn J.A., Clayton R.N. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. Br. Med. J. 313:1996;539-544.
35. Helfand M., Redfern C.C. Screening for thyroid disease: an update. Ann. Intern. M. 129:1998;144-158. (Erratum, Ann. Intern. Med. 1999; 130, 246).
36. American Association of Clinical Endocrinologists releases clinical guidelines for thyroid disease. Am. Fam. Physician. 51:1995;679-680.
37. Faber J., Wünberg N., Schifter S., Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur. J. Endocrinol. 145:2001;391-396.
38. Schlienger J.L., Goichot B., Grunenberger F., Sapin R. Fonction et dysfonction thyroïdiennes des personnes âgées. Rev Med Interne. 17:1996;653-660.
39. Cooper D.S. Subclinical hypothyroidism. N. Engl. J. M. 345:2001;260-265.
40. Tunbridge W.M.G., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. 7:1977;481-493.
41. Sawin C.T., Castelli W.P., Herschman J.M., Mc Namara P., Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham study. Arch. Intern. M. 145:1985;1386-1388.
42. Rosenthal M.J., Hunt W.C., Garry P.J., Goodwin J.S. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. Jama. 258:1987;209.
43. Manciet D., Dartigues J.F., Decamps A., Barberger-Gateau P., Letenneur L., Latapie M.J., et al. The Paquid survery and correlates of subclinical hypothyroidism in elderly community résidents in the southwest of France. Age Ageing. 24:1995;235-241.
44. Vanderpump M.P.J., Tunbridge W.M.G., French J.M., Appleton D., Bates D., Clark F. The incidence of thyroid disorders in the community: a 20-years follow-up of the Whickham survey. Clin. Endocrinol. 43:1995;55-68.
45. Rivolta G., Cerutti R., Colombo R., Mians G., Dionisio P., Grossi E. Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area. J. Endocrinol. Invest. 22:1999;693-697.
46. Pirich C., Müllner M., Sinzinger H. Prevalence and relevance of thyroid dysfonction in 1922 cholesterol screening participants. J. Clin. Epidemiol. 53:2000;623-629.
47. Spyckerelle Y., Steinmetz J., Fournier B., Giordanella J.P., Boulange M., De Talence N. L'hypothyroïdie fruste: aspects épidé miologiques chez les femmes de 45-70 ans. Presse M. 29:2000;885-890.
48. Vanderpump M.P.J., Tunbridge W.M.G., French J.M., Appleton D., Bates D., Clark F., et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-years follow-up study of an English community. Thyroid. 6:1996;155-160.
49. Kabadi U.M. Subclinical hypothyroidism: natural course of the syndrome during a prolonged follow-up study. Arch. Intern. M. 153:1993;957-961.
50. Kahaly G.J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 10:2000;665-679.
51. Biondi B., Fazio S., Palmieri E.A., Carella C., Panza N., Cittadini A., et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 84:1999;2064-2067.
52. Monzani F., Di Bello V., Caraccio N., Bertini A., Giugi D., Guisti C., et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 86:2001;1110-1115.
53. Di Bello V., Monzani F., Giorgi D., Bertini A., Caraccio N., Valenti G., et al. Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J. Am. Soc. Echocardiogr. 13:2000;832-840.
54. Arem R., Rockey R., Kiefe C., Escalante D.A., Rodriguez A. Cardiac systolic and diastolic function at rest and exercice in subclinical hypothyroidism. Effect of thyroid hormones. Thyroid. 6:1996;397-402.
55. Ridgway E.C., Cooper D.S., Walker H., Rodbard D., Maloof F. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 53:1981;1238-1242.
56. Nilsson G., Nordlander S., Levin K. Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med. Sand. 200:1976;63-67.
57. Lithell H., Boberg J., Hellsing K. Serum lipoprotein and apolipoprotein concentrations and tisue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur. J. Clin. Invest. 11:1981;3-10.
58. Vierhapper H., Nardi A., Grösser P., Raber W., Gessi A. Low-density lipoprotein cholesterol in subclinical hypothyroidism. Thyroid. 10:2000;981-984.
59. Tzotzas T., Krassas G.E., Konstantinidis T. Changes in lipoprotein (a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid. 10:2000;803-808.
60. Danese M.D., Ladenson P.W., Meinert C.L., Powe N.R. Effect of thyroxine therapy on serum lipropoteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 85:2000;2993-3001.
61. Kung A.W., Pang R.W., Janus E.D. Elevated serum lipoprotein (a) in subclinical hypothyroidism. Clin. Endocrinol. 43:1995;445-449.
62. Caron P., Calazel C., Parra H.J., Hoff M., Louvet J.P. Decreased HDL-cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin. Endocrinol. 33:1985;519-523.
63. Parle J.V., Franklyn J.A., Cross K.W., Jones S.R., Sheppard M.C. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol. 37:1992;411-414.
64. Bindels A.J., Westendorp R.G., Frolich M., Seidell J.C., Blokstra A., Smelt A.H. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding. Clin. Endocrinol. 50:1999;217-220.
65. Tanis B.C., Westendorp G.J., Smelt A.H.M. Effect of thryoid substitution on hypercholesterolemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin. Endocrinol. 44:1996;643-649.
66. Meier C., Staub J.J., Roth C.B., Guglielmetti M., Kunz M., Miserez A.R., et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial. J Clin Endocrinol Metab. 86:2001;4860-4866.
67. Jayme J.J., Ladenson P.W. Subclinical thyroid dysfunction in the elderly. Trends Endocrinol. Metab. 5:1994;79-86.
68. Mantzoros C.S., Evagelopoulou K., Moses A.C. Outcome of percutaneous transluminal coronary angioplasty in patients with subclinical hypothyroidism. Thyroid. 5:1995;383-387.
69. Hak A.E., Pols H.A.P., Visser T.J., Drexhage H.A., Hofman A., Witterman J.C.M. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. M. 132:2000;170-178.
70. Fatourechi V, Schryver PG, Lankarani M, Vanness DJ, Hall Long K, Klee GG. Increased prevalence of mildly elevated serum TSH levels in patients with coronary heart disease compared to controls. 12th International Thyroid Congress, Kyoto, 22-27 octobre 2000 (Abst P-347).
71. Bastenic P.A., Vanhaelst L., Goldstein J., Smets P.H., Keys A., Karvomen M.J. Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies. Lancet. ii:1977;155-158.
72. Mc Dermott M.T., Ridgway E.C. Subclinical hypothyroidism is mild thyroid failure and should be treated. J. Clin. Endocrinol. Metab. 86:2001;4585-4590.
73. Chu J.W., Crapo L.M. The treatment of subclinical hypothyroidism is seldom necessary. J. Clin. Endocrinol. Metab. 86:2001;4591-4599.